No Data
No Data
Jefferies Initiates Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $40
Silence Therapeutics Analyst Ratings
H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75
Silence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical Advancements
Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading
No Data
No Data